Fragment Screening and Protein Production

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Fragment Screening

Protein Production

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. With all these diverse methods we characterise protein-ligand interactions in many ways. We can screen with many different formats and modalities.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

Sygnature Discovery acquires Peak Proteins

Sygnature Discovery

APRIL 26, 2022

Sygnature have acquired Peak Proteins Ltd. Following an extensive partnership between the two companies, this deal will enable seamless integration of protein production and related structure determination projects within Sygnature. The Peak Proteins leadership team will also remain with the business.

Fragment Screening

Fragment Screening Protein Production Protein Expression Production

Drug Discovery Digest

Target-directed cancer: protein-ligand interactions

Sygnature Discovery acquires Peak Proteins

Stay Connected